Q4 2023 · 13F-HR/A
BML Capital Management, LLCholdings as filed
Filed 2024-02-02 · accession 0001754960-24-000074
$132.0M
Reported value
35
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 46436E718 | SGOV | ISHARES TR | $27.1M | 20.5% | 270,000 | Common | NONE |
| 78468R663 | BIL | SPDR SER TR | $18.3M | 13.8% | 200,000 | Common | NONE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $16.7M | 12.6% | 5,462,079 | Common | NONE |
| 23284P103 | — | CYTEIR THERAPEUTICS INC | $9.9M | 7.48% | 3,250,008 | Common | NONE |
| 89157D105 | TRML | TOURMALINE BIO INC | $6.4M | 4.87% | 245,500 | Common | NONE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $5.9M | 4.46% | 2,180,000 | Common | NONE |
| 05455M100 | — | AVROBIO INC | $5.4M | 4.12% | 4,001,627 | Common | NONE |
| 88369M101 | — | THESEUS PHARMACEUTICALS INC | $4.5M | 3.40% | 1,108,320 | Common | NONE |
| 04746L104 | — | ATHIRA PHARMA INC | $3.5M | 2.68% | 1,454,362 | Common | NONE |
| 00773U108 | ADVMCHF | ADVERUM BIOTECHNOLOGIES INC | $3.4M | 2.60% | 4,554,252 | Common | NONE |
| 002896207 | ANF | ABERCROMBIE & FITCH CO | $3.0M | 2.30% | 900 | PUT | NONE |
| 68403P203 | ORMP | ORAMED PHARMACEUTICALS INC | $2.9M | 2.21% | 1,261,559 | Common | NONE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $2.7M | 2.07% | 1,029,478 | Common | NONE |
| 207523101 | — | CONNECT BIOPHARMA HLDGS LTD | $2.4M | 1.84% | 2,061,438 | Common | NONE |
| 75974E103 | — | RENEO PHARMACEUTICALS INC | $2.1M | 1.59% | 1,314,229 | Common | NONE |
| 046484309 | ASTC | ASTROTECH CORP | $1.9M | 1.42% | 220,410 | Common | NONE |
| 75082Q105 | — | RAIN ONCOLOGY INC | $1.6M | 1.23% | 1,349,007 | Common | NONE |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $1.4M | 1.10% | 1,761,702 | Common | NONE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $1.3M | 1.00% | 180,000 | Common | NONE |
| 974155103 | WING | WINGSTOP INC | $1.2M | 0.92% | 900 | PUT | NONE |
| 00211Y506 | ABIOEUR | ARCA BIOPHARMA INC | $1.2M | 0.91% | 706,930 | Common | NONE |
| 38870X104 | GRPH | GRAPHITE BIO INC | $1.2M | 0.89% | 447,416 | Common | NONE |
| 49705R105 | KNTEUSD | KINNATE BIOPHARMA INC | $1.1M | 0.84% | 468,210 | Common | NONE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $771,000 | 0.58% | 150,000 | Common | NONE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $738,728 | 0.56% | 442,352 | Common | NONE |
| 128058302 | LSTA | LISATA THERAPEUTICS INC | $736,660 | 0.56% | 269,839 | Common | NONE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $692,000 | 0.52% | 50,000 | Common | NONE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $685,762 | 0.52% | 653,107 | Common | NONE |
| 46090E103 | QQQ | INVESCO QQQ TR | $661,200 | 0.50% | 300 | PUT | NONE |
| 64135M105 | NGNE | NEUROGENE INC | $478,027 | 0.36% | 24,666 | Common | NONE |
| 120076104 | BBW | BUILD-A-BEAR WORKSHOP INC | $465,000 | 0.35% | 1,500 | PUT | NONE |
| 438083107 | FIXXEUR | HOMOLOGY MEDICINES INC | $454,850 | 0.34% | 748,108 | Common | NONE |
| 38942Q202 | CALC | CALCIMEDICA INC | $415,913 | 0.32% | 145,424 | Common | NONE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $349,370 | 0.26% | 306,465 | Common | NONE |
| 87424L207 | TLIS | TALIS BIOMEDICAL CORP | $318,435 | 0.24% | 42,743 | Common | NONE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.